Ticker Details
Lexicon Pharmaceuticals, Inc. Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.
IPO Date:	June 23, 2000
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$745.68M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.13 | 3.55%
Avg Daily Range (30 D):	$0.05 | 3.21%
Avg Daily Range (90 D):	$0.05 | 3.40%

Institutional Daily Volume
Avg Daily Volume:	1.27M
Avg Daily Volume (30 D):	2.45M
Avg Daily Volume (90 D):	2.38M

Trade Size
Avg Trade Size (Sh.):	247
Avg Trade Size (Sh.) (30 D):	297
Avg Trade Size (Sh.) (90 D):	318

Institutional Trades
Total Institutional Trades:	1,006
Avg Institutional Trade:	$1.49M
Avg Institutional Trade (30 D):	$1.02M
Avg Institutional Trade (90 D):	$.95M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.29M
Avg Closing Trade (30 D):	$1.74M
Avg Closing Trade (90 D):	$1.15M
Avg Closing Volume:	199.82K

News

Feb 6, 2026 @ 10:17 PM Lexicon Announces Closing of Approximately $94.6 M... Source: Na

Feb 6, 2026 @ 10:17 PM Lexicon Announces Closing of Approximately $94.6 M... Source: Globe Newswire

Jan 30, 2026 @ 7:50 AM Lexicon Announces Pricing of Approximately $94.6 M... Source: Na

Nov 8, 2025 @ 7:30 PM Clinical Data Demonstrating Efficacy of Sotagliflo... Source: Lexicon Pharmaceuticals

Sep 22, 2025 @ 8:00 PM Lexicon Pharmaceuticals Announces Update on Submis... Source: Lexicon Pharmaceuticals

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.14	$-.04	$-.14
Diluted EPS	$-.14	$-.04	$-.14
Revenue	$49.8M	$5.49M	$49.8M
Gross Profit	$49.53M	$5.29M	$49.53M
Net Income / Loss	$-50.34M	$-15.53M	$-50.34M
Operating Income / Loss	$-48.91M	$-14.78M	$-48.91M
Cost of Revenue	$.27M	$.2M	$.27M
Net Cash Flow	$-3.33M	$-15.33M	$-3.33M
PE Ratio

Splits
May 21, 2015	1:7